Safety and efficacy of TNF-inhibitors (adalimumab, infliximab and etanercept) in patients with rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2016
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 12 Aug 2016 New trial record